The regulation of protein synthesis by oxygen
The regulation of protein synthesis by oxygen
批准号:
RGPIN-2015-04807
负责人:
Uniacke, Jim
金额:
$2.84万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-01-01 至 2020-12-31
中文摘要
生物的特点是它们对刺激作出反应和适应的能力。我的研究计划集中在蛋白质合成机制方面的这些特征。蛋白质合成也被称为翻译,是遗传信息从信使核糖核酸(mRNA)流向蛋白质的基本生物学过程。压力环境的变化导致翻译工作的重新聚焦,从维持基本细胞功能转向产生应激反应蛋白。这是通过抑制初级翻译起始机制发生的,初级翻译起始机制通过位于5'端的帽状结构进入mrna,占翻译的95%(帽状依赖翻译)。我的研究项目解决了细胞生物学中的一个主要问题:当帽依赖性翻译受到抑制时,细胞如何在应激期间将它们的mrna翻译成蛋白质?我的研究重点是人类细胞中的缺氧(低氧),因为获得足够的氧气对于产生足够的ATP至关重要,以维持其正常功能,特别是在构成多细胞动物的细胞中。据认为,缺氧细胞在应激过程中从典型的帽依赖翻译(由帽结合蛋白eIF4E介导)转换为帽独立的过程来翻译选择的mrna。我最近证明(Uniacke et al. (2012) Nature),人类细胞适应缺氧需要非规范帽依赖的翻译途径。该途径利用了帽结合蛋白同源物eIF4E2,但仍有许多未解之谜。本提案中概述的项目旨在证明缺氧通过招募专门的翻译因子(项目1)和通过共同调控序列(项目2)的mrna产生专门的帽依赖翻译反应。这些将通过共免疫沉淀、质谱、多体分析、RNA测序、定点诱变和荧光素酶报告基因测定来实现。我们还将研究在包括环境空气、生理和缺氧在内的一系列氧气条件下,哪些帽依赖的翻译机制占主导地位(项目3)。这将通过western blot和mRNA翻译检测监测这些机器的开关活动来实现。我的长期目标是强调帽依赖翻译在一系列细胞应激反应中的多功能性,并证明这些专门的机制在生理氧条件下培养细胞时具有突出的作用。低氧eIF4E2的鉴定被CBC和National Post等媒体报道。我的研究计划将继续对自然科学产生影响,通过影响哺乳动物细胞培养实践,将氧气作为一个变量,并更新当前的转化控制模型。
英文摘要
Living organisms are characterized by their ability to respond to stimuli and adapt. My research program focuses on these characteristics with regard to the protein synthesis machinery. Also known as translation, protein synthesis is a fundamental biological process in the flow of genetic information from messenger ribonucleic acid (mRNA) into protein. Stressful environmental changes lead to a refocusing of translation efforts away from the maintenance of basic cell functions and toward the production of stress response proteins. This occurs by repressing the primary translation initiation machinery, which accesses mRNAs through their cap structure located at the 5' end and accounts for >95% of translation (cap-dependent translation). My research program addresses a major question in cell biology: how do cells translate their mRNAs into proteins during periods of stress when cap-dependent translation is repressed? My focus is on hypoxia (low oxygen) in human cells because the acquisition of adequate oxygen is crucial to produce enough ATP for their proper functioning, especially in cells that constitute multicellular animals. It was believed that hypoxic cells switch from canonical cap-dependent translation (mediated by the cap-binding protein eIF4E) to cap-independent processes to translate select mRNAs during stress. I recently demonstrated (Uniacke et al. (2012) Nature) that a non-canonical cap-dependent translation pathway is required for human cells to adapt to hypoxia. This pathway utilizes the cap-binding protein homolog eIF4E2, but many unanswered questions remain. The projects outlined in this proposal aim to demonstrate that hypoxia creates a specialized cap-dependent translation response through the recruitment of specialized translation factors (project 1) and mRNAs via common regulatory sequences (project 2). These will be achieved through co-immunoprecipitation, mass spectrometry, polysome profiling, RNA sequencing, site-directed mutagenesis, and luciferase reporter assays. We will also investigate which cap-dependent translation machineries are dominant in a range of oxygen conditions that include ambient air, physiological, and hypoxia (project 3). This will be achieved by monitoring the activity of the on and off switches of these machineries through western blot and mRNA translation assays. My long-term goals are to highlight the versatility of cap-dependent translation in response to a range of cellular stresses, and to demonstrate that these specialized machineries have prominent roles when cells are cultured in physiological oxygen conditions. The identification of hypoxic eIF4E2 was covered by media such as the CBC and National Post. My research program will continue to have impacts on the natural sciences by influencing mammalian cell culture practices to include oxygen as a variable, and update current models of translational control.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Regulation of Protein Synthesis by Oxygen
-
批准号:RGPIN-2022-03458
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.5万
-
财政年份:2022
-
负责人:Uniacke, Jim
-
依托单位:
The regulation of protein synthesis by oxygen
-
批准号:RGPIN-2015-04807
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.84万
-
财政年份:2021
-
负责人:Uniacke, Jim
-
依托单位:
The regulation of protein synthesis by oxygen
-
批准号:RGPIN-2015-04807
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.84万
-
财政年份:2020
-
负责人:Uniacke, Jim
-
依托单位:
The regulation of protein synthesis by oxygen
-
批准号:RGPIN-2015-04807
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.84万
-
财政年份:2018
-
负责人:Uniacke, Jim
-
依托单位:
The regulation of protein synthesis by oxygen
-
批准号:RGPIN-2015-04807
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.84万
-
财政年份:2017
-
负责人:Uniacke, Jim
-
依托单位:
The regulation of protein synthesis by oxygen
-
批准号:RGPIN-2015-04807
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.84万
-
财政年份:2016
-
负责人:Uniacke, Jim
-
依托单位:
The regulation of protein synthesis by oxygen
-
批准号:RGPIN-2015-04807
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.84万
-
财政年份:2015
-
负责人:Uniacke, Jim
-
依托单位:
国内基金
海外基金
登录
查看更多内容
子宫内膜间质与巨噬细胞之间通过Protein S-MerTK-Apelin信号对
话促进子宫腺肌病蜕膜化缺陷的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:吕海宁
-
依托单位:
有翅与无翅蚜虫差异分泌唾液蛋白Cuticular protein在调控植物细胞壁免疫中的功能
-
批准号:32372636
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:郭慧娟
-
依托单位:
原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
-
批准号:82371054
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郭涛
-
依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
-
批准号:82370976
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑凌艳
-
依托单位:
细胞周期蛋白依赖性激酶Cdk1介导卵母细胞第一极体重吸收致三倍体发生的调控机制研究
-
批准号:82371660
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:魏喆
-
依托单位:
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
-
批准号:82371798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶俊娜
-
依托单位:
G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
-
批准号:82370865
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:黄哲
-
依托单位:
紧密连接蛋白PARD3下调介导黏膜上皮屏障破坏激活STAT3/SNAI2通路促进口腔白斑病形成及进展的机制研究
-
批准号:82370954
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:沈雪敏
-
依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
-
批准号:82370885
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨
-
依托单位:
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
-
批准号:82371738
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郑英霞
-
依托单位: